AlphaHunt
Healthcare

IDXX Stock Analysis

IDEXX Laboratories, Inc. · current price $552.93 (+1.28% today)

★★★ Average 54/ Alpha Score
Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.
LAST EARNINGS IDEXX Laboratories, Inc. (IDXX)

Latest earnings

EPS
$3.63 vs $3.30 est · +0.1% vs estimate BEAT
Revenue
$1.14B · +2.8% YoY
Stock reaction (1M)
-0.1%
Beat streak
4 of last 4 quarters

Key metrics

Alpha Score
54/100
Grade
C
Rev Growth YoY
+14.3%
30-day Momentum
-0.1%
Forward P/E
40.1×
Analyst Target
$709.14
Implied Upside
+28.6%

Latest news on IDXX

Similar stocks in Healthcare

BIIB WST LLY WAT MRNA HOLX

View all Healthcare stocks →

IDXX — frequently asked

What is IDXX's Alpha Score?

IDEXX Laboratories, Inc. (IDXX) currently has a TickerMover Alpha Score of 54/100, rated ★★★ Average. The Alpha Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is IDEXX Laboratories, Inc. (IDXX) a buy?

TickerMover does not give buy or sell recommendations. IDXX scores 54/100 (★★★ Average) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is IDXX's score updated?

IDXX's Alpha Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF, peer comparison and more — free during beta.

Open dashboard for IDXX →
TickerMover is a research tool, not financial advice. Alpha Score is a composite signal — always do your own research before investing.
Last updated automatically every 5 minutes during US market hours.
Questions? support@tickermover.com